awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40922523-B1602058-B525-4B6A-A766-00D447100BA7
Q40922523-B1602058-B525-4B6A-A766-00D447100BA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40922523-B1602058-B525-4B6A-A766-00D447100BA7
Personalization of targeted therapy in advanced thyroid cancer.
P2860
Q40922523-B1602058-B525-4B6A-A766-00D447100BA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40922523-B1602058-B525-4B6A-A766-00D447100BA7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5704bca6b346e5cee90497c9958a9bc9973da164
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr